Back
HOOKIPA Pharma Quote, Financials, Valuation and Earnings
Sponsored
HOOK
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22
HOOK
HOOKIPA Pharma
Last Price:
4.64
Seasonality Move:
-15.79%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.HOOKIPA Pharma Price Quote
$4.64
-0.03 (-0.64%)
(Updated: September 20, 2024 at 6:55 PM ET)
HOOKIPA Pharma Key Stats
Sell
22
HOOKIPA Pharma (HOOK)
is a Sell
Day range:
$4.60 - $4.75
52-week range:
$4.10 - $11.30
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.06
P/B ratio:
0.54%
Volume:
45.3K
Avg. volume:
24K
1-year change:
-24.13%
Market cap:
$46.2M
Revenue:
$20.1M
EPS:
$-4.32
How Much Does HOOKIPA Pharma Make?
-
How Much Are HOOKIPA Pharma's Sales Annually?
HOOK Revenues are $20.1M -
How Much Profit Does HOOKIPA Pharma's Make A Year?
HOOK net income is -$81.6M
Is HOOKIPA Pharma Growing As A Company?
-
What Is HOOKIPA Pharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.52% -
What Is HOOKIPA Pharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
HOOKIPA Pharma Stock Price Performance
-
Did HOOKIPA Pharma Stock Go Up Last Month?
HOOKIPA Pharma share price went down by -6.79% last month -
Did HOOK's Share Price Rise Over The Last Year?
HOOK share price fell by -24.13% over the past 1 year
What Is HOOKIPA Pharma 52-Week High & Low?
-
What Is HOOKIPA Pharma’s 52-Week High Share Price?
HOOKIPA Pharma has traded as high as $11.30 over the past 52 weeks -
What Is HOOKIPA Pharma’s 52-Week Low Share Price?
HOOKIPA Pharma has traded as low as $4.10 over the past 52 weeks
HOOKIPA Pharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy HOOKIPA Pharma?
-
How Much Debt Does HOOKIPA Pharma Have?
Total long term debt quarterly is $0 -
How Much Cash Does HOOKIPA Pharma Have?
Cash and short term investments quarterly total is $77.2M -
What Is HOOKIPA Pharma’s Book Value Per Share?
Book value per share is 8.70
Is HOOKIPA Pharma Cash Flow Positive?
-
What Is HOOK Cash Flow From Operations?
Cash flow from operations (TTM) is -$73.9M -
What Is HOOKIPA Pharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is $19.3M -
What Is HOOKIPA Pharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$3.6M
HOOKIPA Pharma Return On Invested Capital
-
Is Management Doing A Good Job?
HOOK return on invested capital is -49.37% -
What Is HOOKIPA Pharma Return On Assets?
ROA measures how assets are converting to revenues and is -30.86% -
What Is HOOK Return On Equity?
ROE is a measure of profitability and is -49.81%
HOOKIPA Pharma Earnings Date & Stock Price
-
What Is HOOKIPA Pharma's Stock Price Today?
A single share of HOOK can be purchased today for 4.67 -
What Is HOOKIPA Pharma’s Stock Symbol?
HOOKIPA Pharma trades on the nasdaq under the ticker symbol: HOOK -
When Is HOOKIPA Pharma’s Next Earnings Date?
The next quarterly earnings date for HOOKIPA Pharma is scheduled on November 8, 2024 -
When Is HOOK's next ex-dividend date?
HOOKIPA Pharma's next ex-dividend date is May 26, 2020 -
How To Buy HOOKIPA Pharma Stock?
You can buy HOOKIPA Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
HOOKIPA Pharma Competitors
-
Who Are HOOKIPA Pharma's Competitors?
Below is a list of companies who compete with HOOKIPA Pharma or are related in some way:
HOOKIPA Pharma Dividend Yield
-
What Is HOOK Dividend Yield?
HOOKIPA Pharma’s dividend yield currently is 0% -
What Is HOOKIPA Pharma’s Payout Ratio?
HOOKIPA Pharma’s payout ratio is 0% -
When Did HOOKIPA Pharma Last Pay A Dividend?
The latest dividend pay date is September 21, 2024 -
What Is HOOKIPA Pharma’s Dividend Per Share?
HOOKIPA Pharma pays a dividend of $0.00 per share
HOOKIPA Pharma Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -21.01% |
Revenue: | -51.85% | -81.81% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 43.50 |
Upside from Last Price: | 831.48% |